Completed PHASE4 INTERVENTIONAL 2-arm NCT05871073

Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery

Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery: A Randomized, Double-Blinded, Controlled Trial

Sponsor: University Hospital Fattouma Bourguiba

Conditions Lumbar Disc Herniation Lumbar Spinal Stenosis Lumbar Spine Instability Lumbar Spondylolisthesis

Interventions Ropivacaine 0.75% Injectable Solution dexamethasone 8mg

Updated 3 times since 2023 Last updated: May 13, 2023 Started: Jan 1, 2023 Primary completion: Feb 4, 2023 Completion: Mar 5, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Lumbar Disc Herniation and Lumbar Spinal Stenosis, this trial is completed. The trial is conducted by University Hospital Fattouma Bourguiba and has accumulated 3 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2023 — Jul 2024 [monthly]

Completed PHASE4

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Fattouma Bourguiba

Data source: University Hospital Fattouma Bourguiba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Monastir, Tunisia